GILEAD SCIENCES, INC.

GILD
Biological products no disgnostic substances
Last filing · Annual · Dec 31, 2025
Financial Statements Ratios
Export XLSX
Statement
Income StatementBalance SheetCash Flow
Period
Annual Quarterly
Order

14 more years with Pro

GILEAD SCIENCES, INC. back to 2009, every line as filed.

Create a free account
USD ($)
$ in Millions 		Dec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2018Dec 31, 2017Dec 31, 2016Dec 31, 2015Dec 31, 2014Dec 31, 2013Dec 31, 2012Dec 31, 2011Dec 31, 2010Dec 31, 2009
Operating Activities:
                 
Net income
$ 8,510
$ 480
$ 5,613
Adjustments to reconcile Net income to Net cash provided by operating activities:
                 
Depreciation expense
370
381
354
Amortization expense
2,390
2,386
2,339
Stock-based compensation expense
894
835
766
Deferred income taxes
160
(1,844)
(962)
In-process research and development impairments
590
4,180
50
Excess tax benefits from stock-based compensation
-
-
-
Tax benefits from exercise and vesting of stock-based awards
-
-
-
Tax Benefit from Employee Stock Plans
-
-
-
Tax Benefits from Employee Stock Plans
-
-
-
Net (gain) loss from equity securities
(451)
274
167
Acquired in-process research and development expenses
1,024
4,663
1,155
Up-front and milestone expense related to collaborative and other arrangements
-
-
-
Write-downs for slow-moving and excess raw material and work in process inventory
-
-
-
Write-downs for slow moving and excess raw material and work in process inventory
-
-
-
Other, net
480
353
826
Change in fair value of contingent consideration
-
-
-
Other non-cash transactions
-
-
-
Changes in operating assets and liabilities:
                 
Accounts receivable, net
(367)
139
157
Inventories
(1,036)
(426)
(842)
Prepaid expenses and other
(311)
(259)
39
Accounts payable
(132)
290
(347)
Income tax assets and liabilities, net
(2,108)
(732)
(1,768)
Income taxes payable
-
-
-
Accrued and other liabilities
6
108
458
Deferred revenues
-
-
-
Net cash provided by operating activities
10,019
10,828
8,006
Investing Activities:
                 
Purchases of marketable debt securities
(3,939)
(244)
(1,930)
Proceeds from sales of marketable debt securities
854
2,265
510
Purchases of marketable securities
-
-
-
Proceeds from sales of marketable debt securities
-
-
-
Proceeds from maturities of marketable debt securities
55
327
1,334
Acquisitions, including in-process research and development, net of cash acquired
(1,070)
(4,840)
(1,152)
Up-front and milestone payments related to collaborative and other arrangements
-
-
-
Purchases of equity securities
(133)
(492)
(442)
Purchases of property, plant and equipment
(563)
(523)
(585)
Other investing activities, net
2
58
(1)
Net cash used in investing activities
(4,793)
(3,449)
(2,265)
Financing Activities:
                 
Proceeds from debt financing, net of issuance costs
0
3,464
1,980
Proceeds from convertible note hedges
-
-
-
Purchases of convertible note hedges
-
-
-
Proceeds from issuances of senior notes, net of issuance costs
-
-
-
Proceeds from issuances of convertible notes, net of issuance costs
-
-
-
Proceeds from Sale of Warrants
-
-
-
Proceeds from credit facility
-
-
-
Repayments of credit facility
-
-
-
Proceeds from issuances of common stock
408
422
232
Repurchases of common stock under repurchase programs
(1,922)
(1,150)
(1,000)
Repayments of debt and other obligations
(1,788)
(1,970)
(2,250)
Payments to settle warrants
-
-
-
Extinguishment of long-term debt
-
-
-
Repayments of other long-term obligations
-
-
-
Excess tax benefits from stock-based compensation
-
-
-
Payment of contingent consideration
-
-
-
Payments of dividends
(4,003)
(3,918)
(3,809)
Other financing activities, net
(440)
(281)
(279)
Contributions from (distribution to) noncontrolling interest
-
-
-
Distributions from (to) noncontrolling interest
-
-
-
Net cash used in financing activities
(7,745)
(3,433)
(5,125)
Effect of exchange rate changes on cash and cash equivalents
92
(40)
57
Net change in cash and cash equivalents
(2,428)
3,906
673
Supplemental disclosure of cash flow information:
                 
Interest paid, net of amounts capitalized
-
951
891
Interest paid, net of amounts capitalized
-
-
-
Income taxes paid
-
$ 2,779
$ 3,990